Log In Sign up
The largest database of trusted experimental protocols

C57bl 6 mice b6 cg pds5btg wap erbb2 229wzw j

Manufactured by Jackson ImmunoResearch
Visit Supplier
Sourced in United States, Montenegro

C57BL/6 mice (B6.Cg-Pds5bTg(Wap ERBB2)229Wzw/J) are a genetically modified mouse strain that expresses the ERBB2 gene under the control of the whey acidic protein (Wap) promoter.

Automatically generated - may contain errors

Lab products found in correlation

Cb6f1 mice, by Inotiv (1 mentions)

Spelling variants of this product

C57BL/6 mice (4025 citations) C57BL/6 (2462 citations) C57BL/6 (B6) mice (131 citations) C57BL/6 (B6) (112 citations)

2 protocols using c57bl 6 mice b6 cg pds5btg wap erbb2 229wzw j

1

Tolerant hHER2-transgenic Mice for Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tolerant hHER2-transgenic C57BL/6 mice (B6.Cg-Pds5bTg(Wap ERBB2)229Wzw/J) were obtained from The Jackson Laboratory (Bar Harbor, ME, USA). Mouse colony management and all day-to-day care were performed by trained mouse house staff at Plaisant (Castel Romano, Italy). Female mice (6–8 weeks of age) were used for in vivo experiments.
De Lucia M., Cotugno G., Bignone V., Garzia I., Nocchi L., Langone F., Petrovic B., Sasso E., Pepe S., Froechlich G., Gentile C., Zambrano N., Campadelli-Fiume G., Nicosia A., Scarselli E, & D’Alise A.M. (2020). Retargeted and Multi-cytokine-Armed Herpes Virus Is a Potent Cancer Endovaccine for Local and Systemic Anti-tumor Treatment. Molecular Therapy Oncolytics, 19, 253-264.
+ Open protocol
+ Expand
2

hHER2 Transgenic Mouse Model for Cancer

Check if the same lab product or an alternative is used in the 5 most similar protocols
hHER2-transgenic C57BL/6 mice (B6.Cg-Pds5bTg (Wap ERBB2) 229Wzw/J) were obtained from The Jackson Laboratory (Bar Harbor, ME). CB6F1 mice were purchased from Envigo (Indianapolis, IN). Mouse colony management and all day-to-day care were performed by trained mouse house staff at Plaisant (Castel Romano, Italy). Female mice (6–8 weeks of age) were used for in vivo experiments.
All of the experimental procedures were approved by the Italian Ministry of Health (Authorizations 213/2016 PR) and have been done in accordance with the applicable Italian laws (D.L.vo 26/14 and following amendments), the Institutional Animal Care and ethic Committee of CEINGE and Allevamenti Plaisant S.r.l.
Troise F., Leoni G., Sasso E., Del Sorbo M., Esposito M., Romano G., Allocca S., Froechlich G., Cotugno G., Capone S., Folgori A., Scarselli E., D’Alise A.M, & Nicosia A. (2024). Prime and pull of T cell responses against cancer-exogenous antigens is effective against CPI-resistant tumors. Molecular Therapy Oncology, 32(1), 200760.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!